Skip to content

Advertisement

 ANC: Neuroscience of Disease

Editors-in-Chief

Jeroen Hoozemans, VU University Medical Center, The Netherlands
Jason Huse, Memorial Sloan Kettering Cancer Center, USA

Aims and scope

Acta Neuropathologica Communications (ANC) focuses on the pathogenesis of neurological disease using experimental or human tissues, molecular, cellular, biological and morphological techniques

EUROTAU Series: Reflections on the Status Quo

New Content Item

EUROTAU is an innovative, collaborative research initiative established to tackle unanswered research questions and the mounting challenges posed by Tauopathies. EUROTAU provides a forum for promoting ambitious, innovative, multi-national and multi-disciplinary collaborative research projects, that: i) combine experimental approaches from fundamental, pre-clinical and/or clinical with computational approaches; ii) perform network analyses in different Tauopathies to elucidate the underlying mechanisms that are common as well as those that are different between them, and iii) will add value to existing research by analyzing diseases across traditional clinical boundaries, thereby gaining deeper understanding of the patho-physiological mechanisms of these disorders.  

View the articles here

Articles

  1. Content type: Review

      |  

    Authors: Santosh Jadhav, Jesus Avila, Michael Schöll, Gabor G. Kovacs, Enikö Kövari, Rostislav Skrabana, Lewis D Evans, Eva Kontsekova, Barbara Malawska, Rohan de Silva, Luc Buee and Norbert Zilka

Most accessed articles RSS

View all articles

New Content Item

Featured Article: New zebrafish model for ALS/FTD

Shaw et al. generate a novel transgenic zebrafish model to investigate the key pathological profile of human amyotrophic lateral sclerosis/fronto-temporal dementia, providing a valuable tool for future drug discovery.

Why publish with ANC?

  • No major revisions: only minor revisions are requested that can be performed (and have to be performed) within 3 weeks
  • Fast, thorough peer review: group of editors selected on the basis of their insightful, dedicated and prompt service
  • Rapid publication: publication within 2 months of submission
  • Inclusion in all major indexing services, such as PubMed, MEDLINE and Web of Science
  • Open access: enabling it to be read by a much larger set of readers, increasing its visibility
  • Competitive APC: flat article-processing charge, with no page limits, color figure charges or submission fees

Our Commitment to excellent author service

ANC is committed to rapid publication. We aim to publish all research articles within 2 months of submission, subject to authors responding to requests within the required timeframe. If the publication of your article exceeds 2 months from submission, you may be entitled to a full waiver or discount of the article-processing charge on your next submission. For further information, please read our FAQs or contact editorial@actaneurocomms.org

Sister journal

ANC is sister journal to Acta Neuropathologica, a journal dedicated to the pathology and mechanisms of neurological disease.

Read more here


From the Editors-in-Chief

Johannes

"Acta Neuropathologica Communications is a journal for researchers working on human neurological disease and has a focus on neuropathology. However, since we believe that an interdisciplinary approach is highly valuable to advance the field, our journal is not restricted to classical neuropathological articles. Therefore, we also welcome high-quality submissions from other disciplines as long as they do ultimately aim to advance our understanding of human neurological disease. We try our best to help you with the submission process and in case of any questions do not hesitate to contact the Editors-in-Chief directly."

Johannes Attems, co-Editor-in-Chief, ANC

New Content Item

"The unique combination of human neuropathology with relevant experimental models is essential for understanding the pathogenesis of neurological diseases. Acta Neuropathologica Communications provides a platform for studies that centrally involve human neuropathology and bring new insight in disease mechanisms of neurological diseases using relevant experimental models. We welcome high quality papers that do not require major revisions, resulting in short turn-around times and fast publication. We hope you enjoy Acta Neuropathologica Communications and are looking forward to receive your submissions."

Jeroen Hoozemans, co-Editor-in-Chief, ANC

Advertisement

Logo

Annual Journal Metrics

Advertisement